Elixir Biotech India Private Limited
About Elixir Biotech India Private Limited
Data last updated:
Elixir Biotech India Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74900UP2009PTC037038.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Amit Kumar Gupta and Bal Chand Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 100 Mig Phase – 1 Rapti Nagar Post Arogya Mandir, Gorakhpur, Uttar Pradesh, India – 273003.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.02 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹1,415 (net margin 0%) and EBITDA of ₹21,038 (EBITDA margin 0.6%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Elixir Biotech India Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address100 Mig Phase – 1 Rapti Nagar Post Arogya Mandir, Gorakhpur, Uttar Pradesh, India – 273003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Elixir Biotech India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elixir Biotech India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elixir Biotech India Private Limited, buy the company report.
Financials of Elixir Biotech India Private Limited
FY 2025 filings availableElixir Biotech India Private Limited reported revenue of ₹34.02 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,038 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,415 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elixir Biotech India Private Limited, buy the company report.
Board of directors of Elixir Biotech India Private Limited
Elixir Biotech India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Gupta Also directs: Awadh Luxury Home Developers Private Limited | Director | 24 Mar 2009 | 17 Years 7 Months | Current |
| Shambhu Singh | Additional Director | 12 Mar 2012 | 14 Years 7 Months | Current |
| Bal Chand Gupta Also directs: Shyamlata Commodities Private Limited | Director | 24 Mar 2009 | 17 Years 7 Months | Current |
Peer comparison
Elixir Biotech India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goodness Pharmaceuticals Private Limited | ₹34.21 Lakh (FY 2022) | 6.0% | Aligarh, Uttar Pradesh, India | |||
| Dew Lifecare Private Limited | ₹34.18 Lakh (FY 2024) | 18.0% | Vadodara, Gujarat, India | |||
| Solway Pharmaceuticals Private Limited | ₹34.16 Lakh (FY 2025) | -11.0% | Ambala Cantt, Haryana, India | |||
| Elixir Biotech India Private Limitedthis company | ₹34.02 Lakh (FY 2025) | ₹1,415 | 0% | 4.0% | Gorakhpur, Uttar Pradesh, India | |
| Saskia Healthcare Private Limited | ₹33.79 Lakh (FY 2024) | 63.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Elixir Biotech India Private Limited, buy the company report.
Auditor
Elixir Biotech India Private Limited is audited by RAJESH SUSHIL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH SUSHIL & CO | FY 2021 | 010074C |
Shareholding
The shareholding of Elixir Biotech India Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Elixir Biotech India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elixir Biotech India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elixir Biotech India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Elixir Biotech India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Elixir Biotech India Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Shambhu Singh was appointed as Additional Director on 12 Mar 2012.
Frequently asked questions
Elixir Biotech India is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 March 2009 (17+ years old) and is registered under CIN U74900UP2009PTC037038.
Elixir Biotech India has 3 current directors:
- Amit Kumar Gupta - Director
- Shambhu Singh - Additional Director
- Bal Chand Gupta - Director
The latest financial statements of Elixir Biotech India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Elixir Biotech India is U74900UP2009PTC037038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elixir Biotech India was incorporated on 24 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Elixir Biotech India by revenue are Goodness Pharmaceuticals Private Limited, Dew Lifecare Private Limited, Solway Pharmaceuticals Private Limited, Saskia Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Shambhu Singh was appointed as Additional Director on 12 Mar 2012. Amit Kumar Gupta was appointed as Director on 24 Mar 2009. Bal Chand Gupta was appointed as Director on 24 Mar 2009.
The registered office of Elixir Biotech India is at 100 Mig Phase – 1 Rapti Nagar Post Arogya Mandir, Gorakhpur, Uttar Pradesh, India – 273003.
Elixir Biotech India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Elixir Biotech India is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Elixir Biotech India can be reached at its registered office: 100 Mig Phase – 1 Rapti Nagar Post Arogya Mandir, Gorakhpur, Uttar Pradesh, India – 273003.